An antibody is a protein that develops in the body as a normal course of the immune response to various types of infections. The global Custom Antibody market is projected to rise at a significant rate in the next few years. The incidences of infectious diseases have been increasing across the world. These rising diseases are boosting the demand for custom antibodies. This key fact majorly contributes to the growth of the global Custom Antibody market.
Moreover, there is also rising demand across the world for protein therapeutics. Production of custom antibodies and related services are key for protein therapeutics. This fact further propelling the growth of the global Custom Antibody market. Currently, custom antibody production, particularly monoclonal antibodies has experienced clinical as well as commercial success. This success is also supporting to fuel the growth of the global Custom Antibody market.
However, the time and expense involved in the production of these antibodies is the key challenge faced by the global Custom Antibody market. Besides this, growing healthcare investments by both government and industry leaders are anticipated to drive the market in the forthcoming years.
Covid-19 Impact on Custom Antibody Market:
In addition, the current Custom Antibody Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Custom Antibody Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Custom Antibody Market Segment Overview
Based on the service, the Antibody Development segment accounted for the largest share in the Custom Antibody market in 2020. The large share of this segment can be attributed to the increasing focus of researchers on high-quality custom antibodies for reproducibility, which can be hindered when using commercially available antibodies. Additionally, by type, the monoclonal antibodies segment has significant growth in the market in 2020. This is because monoclonal antibodies provide high specificity and selectivity compared to other antibodies and are thus the preferred choice in all types of research studies. In addition, by source, the mice segment accounted for the largest share of the market. Mice are the most preferred hosts for research-use antibody production. Compared to other experimental animals, mice offer advantages of lower feeding costs and ease of maintenance & handling due to their small size.
Custom Antibody Market, By Service
· Antibody Development
· Antibody Production & Purification
· Antibody Fragmentation & Labeling
Custom Antibody Market, By Type
· Monoclonal Antibodies
· Polyclonal Antibodies
· Recombinant Antibodies
· Other Custom Antibodies
Custom Antibody Market, By Source
· Mice
· Rabbits
· Other Sources
Custom Antibody Market, By Research Area
· Oncology
· Infectious Diseases
· Neurobiology
· Stem Cells
· Immunology
· Cardiovascular Disease
· Other Research Areas
Custom Antibody Market, By End User
· Pharmaceutical & Biotechnology Companies
· Academic & Research Institutes
· Contract Research Organizations
Custom Antibody Market Regional Overview
Region-wise, North America accounted for the largest share in the custom antibody market. This can be mainly attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and the increasing focus on developing antibody-based therapeutics in this region. Similarly, the market of the Asia Pacific is expected to grow at a significant pace. This growth is attributed to the rise of developing countries such as India and China. Such developing countries are largely investing in life science and genomics research.
Custom Antibody Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Custom Antibody Market Competitor overview
Some key developments and strategies adopted by manufacturers in Custom Antibody are highlighted below.
· In 2018, industry leader Abcam launched two new custom antibodies in the custom antibody market. These antibodies are called (PBS)-only recombinant antibodies and anti-PD-L1 antibody clone called MKP1A07310. These custom antibodies are developed by Abcam in collaboration with German giants Merck KGaA.
Custom Antibody Market, Key Players
· Innovagen AB
· ProteoGenix
· Agilent Technologies Inc.
· Bio-Rad Laboratories Inc.
· Abcam Plc
· Thermo Fisher Scientific Inc.
· Merck Group
· Cell Signaling Technology, Inc.
· GenScript
· BioLegend
· Rockland Immunochemicals
1.Introduction
- 1.1.Research Scope
- 1.2.Market Segmentation
- 1.3.Research Methodology
- 1.4.Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
- 3.1.Market Drivers
- 3.2.Market Restraints
- 3.3.Market Opportunities
4.Key Insights
- 4.1.Key Emerging Trends – For Major Countries
- 4.2.Latest Technological Advancement
- 4.3.Regulatory Landscape
- 4.4.Industry SWOT Analysis
- 4.5.Porters Five Forces Analysis
5.Global Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1.Key Findings / Summary
- 5.2.Market Analysis, Insights and Forecast – By Service
- 5.2.1.Antibody Development
- 5.2.2.Antibody Production & Purification
- 5.2.3.Antibody Fragmentation & Labeling
- 5.3.Market Analysis, Insights and Forecast – By Type
- 5.3.1.Monoclonal Antibodies
- 5.3.2.Polyclonal Antibodies
- 5.3.3.Recombinant Antibodies
- 5.3.4.Other Custom Antibodies
- 5.4.Market Analysis, Insights and Forecast – By Source
- 5.4.1.Mice
- 5.4.2.Rabbits
- 5.4.3.Other Sources
- 5.5.Market Analysis, Insights and Forecast – By Research Area
- 5.5.1.Oncology
- 5.5.2.Infectious Diseases
- 5.5.3.Neurobiology
- 5.5.4.Stem Cells
- 5.5.5.Immunology
- 5.5.6.Cardiovascular Disease
- 5.5.7.Other Research Areas
- 5.6.Market Analysis, Insights and Forecast – By End User
- 5.6.1.Pharmaceutical & Biotechnology Companies
- 5.6.2.Academic & Research Institutes
- 5.6.3.Contract Research Organizations
- 5.7.Market Analysis, Insights and Forecast – By Region
- 5.7.1.North America
- 5.7.2.Europe
- 5.7.3.Asia Pacific
- 5.7.4.Latin America, Middle East and Africa
6.North America Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1.Key Findings / Summary
- 6.2.Market Analysis, Insights and Forecast – By Service
- 6.2.1.Antibody Development
- 6.2.2.Antibody Production & Purification
- 6.2.3.Antibody Fragmentation & Labeling
- 6.3.Market Analysis, Insights and Forecast – By Type
- 6.3.1.Monoclonal Antibodies
- 6.3.2.Polyclonal Antibodies
- 6.3.3.Recombinant Antibodies
- 6.3.4.Other Custom Antibodies
- 6.4.Market Analysis, Insights and Forecast – By Source
- 6.4.1.Mice
- 6.4.2.Rabbits
- 6.4.3.Other Sources
- 6.5.Market Analysis, Insights and Forecast – By Research Area
- 6.5.1.Oncology
- 6.5.2.Infectious Diseases
- 6.5.3.Neurobiology
- 6.5.4.Stem Cells
- 6.5.5.Immunology
- 6.5.6.Cardiovascular Disease
- 6.5.7.Other Research Areas
- 6.6.Market Analysis, Insights and Forecast – By End User
- 6.6.1.Pharmaceutical & Biotechnology Companies
- 6.6.2.Academic & Research Institutes
- 6.6.3.Contract Research Organizations
- 6.7.Market Analysis, Insights and Forecast – By Country
- 6.7.1.U.S.
- 6.7.2.Canada
7.Europe Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Service
- 7.2.1.Antibody Development
- 7.2.2.Antibody Production & Purification
- 7.2.3.Antibody Fragmentation & Labeling
- 7.3.Market Analysis, Insights and Forecast – By Type
- 7.3.1.Monoclonal Antibodies
- 7.3.2.Polyclonal Antibodies
- 7.3.3.Recombinant Antibodies
- 7.3.4.Other Custom Antibodies
- 7.4.Market Analysis, Insights and Forecast – By Source
- 7.4.1.Mice
- 7.4.2.Rabbits
- 7.4.3.Other Sources
- 7.5.Market Analysis, Insights and Forecast – By Research Area
- 7.5.1.Oncology
- 7.5.2.Infectious Diseases
- 7.5.3.Neurobiology
- 7.5.4.Stem Cells
- 7.5.5.Immunology
- 7.5.6.Cardiovascular Disease
- 7.5.7.Other Research Areas
- 7.6.Market Analysis, Insights and Forecast – By End User
- 7.6.1.Pharmaceutical & Biotechnology Companies
- 7.6.2.Academic & Research Institutes
- 7.6.3.Contract Research Organizations
- 7.7.Market Analysis, Insights and Forecast – By Country
- 7.7.1. UK
- 7.7.2.Germany
- 7.7.3.France
- 7.7.4.Italy
- 7.7.5.Spain
- 7.7.6.Russia
- 7.7.7.Rest of Europe
8.Asia Pacific Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Service
- 8.2.1.Antibody Development
- 8.2.2.Antibody Production & Purification
- 8.2.3.Antibody Fragmentation & Labeling
- 8.3.Market Analysis, Insights and Forecast – By Type
- 8.3.1.Monoclonal Antibodies
- 8.3.2.Polyclonal Antibodies
- 8.3.3.Recombinant Antibodies
- 8.3.4.Other Custom Antibodies
- 8.4.Market Analysis, Insights and Forecast – By Source
- 8.4.1.Mice
- 8.4.2.Rabbits
- 8.4.3.Other Sources
- 8.5.Market Analysis, Insights and Forecast – By Research Area
- 8.5.1.Oncology
- 8.5.2.Infectious Diseases
- 8.5.3.Neurobiology
- 8.5.4.Stem Cells
- 8.5.5.Immunology
- 8.5.6.Cardiovascular Disease
- 8.5.7.Other Research Areas
- 8.6.Market Analysis, Insights and Forecast – By End User
- 8.6.1.Pharmaceutical & Biotechnology Companies
- 8.6.2.Academic & Research Institutes
- 8.6.3.Contract Research Organizations
- 8.7.Market Analysis, Insights and Forecast – By Country
- 8.7.1.China
- 8.7.2.India
- 8.7.3.Japan
- 8.7.4.Australia
- 8.7.5.South East Asia
- 8.7.6.Rest of Asia Pacific
9.Latin America, Middle East and Africa Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1.Key Findings / Summary
- 9.2.Market Analysis, Insights and Forecast – By Service
- 9.2.1.Antibody Development
- 9.2.2.Antibody Production & Purification
- 9.2.3.Antibody Fragmentation & Labeling
- 9.3.Market Analysis, Insights and Forecast – By Type
- 9.3.1.Monoclonal Antibodies
- 9.3.2.Polyclonal Antibodies
- 9.3.3.Recombinant Antibodies
- 9.3.4.Other Custom Antibodies
- 9.4.Market Analysis, Insights and Forecast – By Source
- 9.4.1.Mice
- 9.4.2.Rabbits
- 9.4.3.Other Sources
- 9.5.Market Analysis, Insights and Forecast – By Research Area
- 9.5.1.Oncology
- 9.5.2.Infectious Diseases
- 9.5.3.Neurobiology
- 9.5.4.Stem Cells
- 9.5.5.Immunology
- 9.5.6.Cardiovascular Disease
- 9.5.7.Other Research Areas
- 9.6.Market Analysis, Insights and Forecast – By End User
- 9.6.1.Pharmaceutical & Biotechnology Companies
- 9.6.2.Academic & Research Institutes
- 9.6.3.Contract Research Organizations
- 9.7.Market Analysis, Insights and Forecast – By Country
- 9.7.1.Brazil
- 9.7.2.Saudi Arabia
- 9.7.3.UAE
- 9.7.4.Rest of LAMEA
10.Competitive Analysis
- 10.1.Company Market Share Analysis, 2018
- 10.2.Key Industry Developments
- 10.3.Company Profile
- 10.4.Innovagen AB
- 10.4.1.Business Overview
- 10.4.2.Segment 1 & Service Offering
- 10.4.3.Overall Revenue
- 10.4.4.Geographic Presence
- 10.4.5.Recent Development
- 10.5.ProteoGenix
- 10.6.Agilent Technologies Inc.
- 10.7.Bio-Rad Laboratories Inc.
- 10.8.Abcam Plc
- 10.9.Thermo Fisher Scientific Inc.
- 10.10.Merck Group
- 10.11.Cell Signaling Technology, Inc.
- 10.12.GenScript
- 10.13.BioLegend
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
